Sparteine
CARDIOVASCULAR SYSTEM
Also known as: (-)-Sparteine, l-Sparteine, lupinidin, lupinidine, spartein, sparteine sulfate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Sparteine is a drug catalogued in DrugCentral.
- ATC code: C01BA04 (Antiarrhythmics, class Ia).
- Molecular formula: C15H26N2; molecular weight 234.39 g/mol.
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C01BA04 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › ANTIARRHYTHMICS, CLASS I AND III › Antiarrhythmics, class Ia |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Sparteine is on its molecule page.
| Molecular formula | C15H26N2 |
|---|---|
| Molecular weight | 234.39 g/mol |
| CAS number | 90-39-1 |
| InChIKey | SLRCCWJSBJZJBV-ZQDZILKHSA-N |
| PubChem CID | 644020 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Sparteine?
Sparteine has the molecular formula C15H26N2 and a molecular weight of 234.39 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2467 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1908348 — compound record and bioactivity
- PubChem CID 644020 — chemical identifiers
- DrugBank DB06727 — drug record
- FDA UNII 298897D62S — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.